News
In the third part of his Pharma Commerce video interview, Dave Malenfant, a healthcare supply chain expert, discusses how predictive analytics, AI, and automation are streamlining US pharmaceutical ...
Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives ...
AGI Fabricators, a provider of metal structural fabrication solutions, today emphasizes the breadth of its fabrication and ...
Natco Pharma launches Bosentan tablets, generic version of Tracleer, with 180-day exclusivity in the U.S. for PAH treatment.
The CDMO will be cutting 350 jobs at its Baltimore gene therapy site after a major client’s demand shift, less than a year after Novo Holdings’ $16.5 billion acquisition.
Nearly two-thirds of US drug production facilities are located in areas that have had a major disaster like a fire or ...
In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...
3h
Zacks Investment Research on MSNGEHC Positioned for Growth With AI, Global Expansion and Margins
GE HealthCare Technologies GEHC posted a solid second-quarter 2025 earnings report, underscoring its ability to deliver ...
The Global Mass Spectrometry Market size valued at approximately USD 6.9 billion in 2024, is projected to reach USD 10.38 billion by 2030, growing at ...
4h
Zacks Investment Research on MSNDoes Cobenfy Have the Potential to Become a Top Drug for BMY?
Bristol Myers BMY won FDA approval for xanomelineand trospiumchloride (formerly KarXT), an oral medication for the treatment ...
Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...
Learn more about whether Ocular Therapeutix, Inc. or Organon & Co. is a better investment based on AAII's A+ Investor grades, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results